The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AGN-PC-00HZ60     4-bromocyclohex-2-ene-1,5,6- triol

Synonyms: AG-F-49374, SureCN3943598, AC1L3TWJ, CTK1D6405, AR-1H1113, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Bromoconduritol

 

High impact information on Bromoconduritol

 

Biological context of Bromoconduritol

  • Significant inhibition of fusion was obtained at concentrations as low as 50 micrograms of bromoconduritol/mL, whereas inhibition of cell growth did not occur until concentrations of 250 micrograms/mL were reached [9].
 

Analytical, diagnostic and therapeutic context of Bromoconduritol

  • Analysis of the iodinated proteins by two-dimensional gel electrophoresis demonstrated that a number of high-molecular-weight proteins (greater than 90,000) detected at the surface of control cells were absent from the surface of cells treated with MDJN or bromoconduritol [9].

References

  1. Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol. Datema, R., Romero, P.A., Legler, G., Schwarz, R.T. Proc. Natl. Acad. Sci. U.S.A. (1982) [Pubmed]
  2. Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. Pulverer, G., Beuth, J., Ko, H.L., Yassin, A., Ohshima, Y., Roszkowski, K., Uhlenbruck, G. J. Cancer Res. Clin. Oncol. (1988) [Pubmed]
  3. Bromoconduritol treatment delays intracellular transport of secretory glycoproteins in human hepatoma cell cultures. Yeo, K.T., Yeo, T.K., Olden, K. Biochem. Biophys. Res. Commun. (1989) [Pubmed]
  4. On the role of oligosaccharide trimming in the maturation of Sindbis and influenza virus. Datema, R., Romero, P.A., Rott, R., Schwarz, R.T. Arch. Virol. (1984) [Pubmed]
  5. Effect of bromoconduritol on glucosidase II from rat liver. A new kinetic model for the binding and hydrolysis of the substrate. Alonso, J.M., Santa-Cecilia, A., Calvo, P. Eur. J. Biochem. (1993) [Pubmed]
  6. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F. Legler, G., Bieberich, E. Arch. Biochem. Biophys. (1988) [Pubmed]
  7. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3. Tanaka, Y., Kato, J., Kohara, M., Galinski, M.S. Antiviral Res. (2006) [Pubmed]
  8. Effect of the alpha-glucosidase inhibitor, bromoconduritol, on carbohydrate metabolism in the silverleaf whitefly, Bemisia argentifolii. Salvucci, M. Arch. Insect Biochem. Physiol. (2000) [Pubmed]
  9. Inhibition of myoblast fusion by bromoconduritol. Trudel, G.C., Herscovics, A., Holland, P.C. Biochem. Cell Biol. (1988) [Pubmed]
 
WikiGenes - Universities